DeepMed Research

University of Kansas Medical Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1906-01-01

Employees: 5K

Market Cap: -

Website: https://www.kumc.edu

Clinical Trials

Chronic Pain, Opioid Use, and Epidermal Nerve Fiber Density

Completed

Conditions: Opioid Use
Nerve Disorders
Chronic Pain

First Posted Date: 2021-03-17

Last Posted Date: 2024-11-06

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 38

Registration Number: NCT04801498

Locations: 🇺🇸
University of Kansas Health System, Kansas City, Kansas, United States

Phase III Trial of Sirolimus in IBM

Phase 3

Active, not recruiting

Conditions: Inclusion Body Myositis

Interventions: Drug: Placebo
Drug: Sirolimus

First Posted Date: 2021-03-09

Last Posted Date: 2025-02-14

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 140

Registration Number: NCT04789070

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇦🇺
Concord Repatriation Hospital, Sydney, New South Wales, Australia

and more 6 locations

The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers

Phase 1

Recruiting

Conditions: Advanced Biliary Tract Cancer

Interventions: Drug: Durvalumab
Drug: Regorafenib

First Posted Date: 2021-03-04

Last Posted Date: 2024-02-23

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 40

Registration Number: NCT04781192

Locations: 🇺🇸
University of Kansas Cancer Center - Overland Park, Overland Park, Kansas, United States
🇺🇸
University of Kansas Cancer Center - North, Kansas City, Missouri, United States
🇺🇸
University of Kansas Cancer Center - Lee's Summit, Lee's Summit, Missouri, United States

and more 1 locations

KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice

Not Applicable

Completed

Conditions: Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer

Interventions: Behavioral: Telementoring with Practice Facilitation

First Posted Date: 2021-02-21

Last Posted Date: 2024-06-07

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 267

Registration Number: NCT04763824

Locations: 🇺🇸
University of Kansas Cancer Center, Westwood, Kansas, United States

Evaluation of Multi-Tined Expandable Electrode (MEE) Efficacy and Safety in Treatment of Lumbar Facet Arthropathy by Radiofrequency Neurotomies Compared to Conservative Medical Management.

Not Applicable

Recruiting

Conditions: Chronic Low-back Pain

Interventions: Procedure: Radiofrequency Ablation with MEE
Behavioral: Conventional Medical Management

First Posted Date: 2021-01-29

Last Posted Date: 2024-10-22

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 50

Registration Number: NCT04730700

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Phase 1

Recruiting

Conditions: Hypertension
Cardiovascular Diseases

Interventions: Drug: Saline
Drug: Ascorbic acid solution (American Regent Laboratories Inc.)

First Posted Date: 2021-01-20

Last Posted Date: 2023-10-24

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 23

Registration Number: NCT04715022

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction

Early Phase 1

Active, not recruiting

Conditions: Chronic Pain
Diuretics Drug Reactions
Hypertension
SCS

Interventions: Drug: Hydrochlorothiazide 12.5mg
Drug: Placebo

First Posted Date: 2020-12-21

Last Posted Date: 2024-10-08

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 36

Registration Number: NCT04676399

Locations: 🇺🇸
The Marc A. Asher Comprehensive Spine Center at the Kansas University Medical Center, Kansas City, Kansas, United States

129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study

Phase 2

Withdrawn

Conditions: Idiopathic Pulmonary Fibrosis
Hypersensitivity Pneumonitis

Interventions: Drug: Hyperpolarized Xe129

First Posted Date: 2020-12-21

Last Posted Date: 2022-09-10

Lead Sponsor: University of Kansas Medical Center

Registration Number: NCT04677426

Blood Flow Response and Acute INterval Exercise

Completed

Conditions: Stroke
High Intensity Interval Exercise

Interventions: Behavioral: Single, acute bout of high intensity interval exercise

First Posted Date: 2020-12-17

Last Posted Date: 2023-02-09

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 91

Registration Number: NCT04673994

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

Hyperpolarized 129Xe MRI of Survivors of COVID-19

Phase 1

Active, not recruiting

Conditions: Covid19

Interventions: Drug: Hyperpolarized Xe129

First Posted Date: 2020-12-09

Last Posted Date: 2025-04-04

Lead Sponsor: University of Kansas Medical Center

Target Recruit Count: 20

Registration Number: NCT04659707

Locations: 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy